Year-over-year earnings per share growth for the last twelve months: Cytek Biosciences, Inc. (CTKB)
Quarterly EPS dynamics correlate with funding for biotech startups and universities, upon which Cytek Biosciences (CTKB) system sales depend. The value of -9.00 reflects this status, considering the risks of reduced medical investment in the US and prolonged deal cycles. Meanwhile, the business relies on a consumables model: the sale of analyzers ensures a stable margin through the regular sale of reagents.
Cytek Corp - analytical breakdowns and key metrics (CTKB)
- share price and expert price forecast:
- company stock exchange capitalization indicators:
- book capitalization data:
- debt level and financial liquidity data:
Total Debt to Equity Ratio Cytek Biosciences, Inc.|CTKB - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital Cytek Biosciences, Inc.|CTKB - Company Cumulative Debt|Debt to Book Capitalization Ratio Cytek Bio|CTKB - Company Long-Term Debts|Company Current Liabilities Cytek Biosciences|Quick Ratio cytekbio.com
- earnings and valuation multiples indicators:
CTKB - Company Net Income|Projected Future Earnings Cytek Biosciences, Inc.|CTKB - Business Payback Period|Future Price to Earnings Cytek Bio|CTKB - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cytek Bio|CTKB - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Cytek Biosciences|CTKB - Net earnings per share for the last 12 months|Quarterly EPS earnings growth cytekbio.com|CTKB - Expected net earnings per share growth this year|Earnings growth forecast for next year Cytek Biosciences, Inc.
Comprehensive company analysis:Cytek Biosciences, Inc.
This metric reflects the dynamics of earnings per share compared to the same quarter last year. Growth in this metric confirms operational efficiency and the business's ability to scale profitability. For Cytek Biosciences, Inc. (CTKB), this directly depends on the reliability of specialized medical logistics during the delivery of analysis systems. Optimizing transportation reduces costs, which is reflected in the shift of the quarterly EPS level. This trend allows investors to assess the real resilience of the company.
Competitor analysis
A: Quarterly EPS earnings growth|DGX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Illumina Corp|Exact Sciences Inc. (EXAS) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth RVTY|Year-over-year net earnings per share growth for the last 12 months bio-rad.com BIO|Anbio - Year-over-year net earnings per share growth for the last 12 months|Sotera Health Corp (SHC) - Earnings per share growth in annualized terms for the last twelve months|QDEL: Year-over-year net earnings per share growth for the last 12 months|OPKO Health Corp. - Year-over-year earnings per share growth rate for the last twelve months|CDNA: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months maravai.com (MRVI)|Year-over-year earnings per share growth for the last twelve months Fulgent Genetics|Quarterly EPS earnings growth Standard BioTools Inc|Year-over-year net earnings per share growth for the last 12 months OSUR (OraSure Technologies Inc)|XGN (exagen.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth MDXH (MDxHealth SA)|luciddx.com - Year-over-year earnings per share growth for the last twelve months|Prenetics Global Ltd - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Insight Molecular Diagnostics IMDX|trinitybiotech.com (TRIB) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months ProPhase Labs Corp (PRPH)|Year-over-year earnings per share growth for the last twelve months Ainos, Inc.|codiagnostics.com (CODX) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth HSCS|Year-over-year net earnings per share growth for the last 12 months Biomerica Inc. BMRA|Quarterly EPS earnings growth CDIO (Cardio Diagnostics Holdings)|Year-over-year net earnings per share change for the last twelve months Onconetix Corporation (ONCO)|Virax Biolabs Group - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months bluejaydx.com|Aspira Women's Health Inc. (AWH) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months AXDX|CNTG (CENTOGENE) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Enzo (ENZ)|Quarterly EPS earnings growth FRES|GENE - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months 23andMe ME|Year-over-year net earnings per share change for the last twelve months Psychemedics Corp. (PMD)
